These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21742304)

  • 1. Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis.
    Holbrook JT; Colvin R; van Natta ML; Thorne JE; Bardsley M; Jabs DA;
    Am J Ophthalmol; 2011 Oct; 152(4):628-637.e1. PubMed ID: 21742304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes.
    Jabs DA; Ahuja A; Van Natta M; Lyon A; Srivastava S; Gangaputra S;
    Ophthalmology; 2010 Nov; 117(11):2152-61.e1-2. PubMed ID: 20673591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy.
    Robinson MR; Reed G; Csaky KG; Polis MA; Whitcup SM
    Am J Ophthalmol; 2000 Jul; 130(1):49-56. PubMed ID: 11004259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis.
    Song MK; Azen SP; Buley A; Torriani F; Cheng L; Chaidhawangul S; Ozerdem U; Scholz B; Freeman WR
    Am J Ophthalmol; 2003 Oct; 136(4):696-702. PubMed ID: 14516810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term Outcomes of Cytomegalovirus Retinitis in the Era of Modern Antiretroviral Therapy: Results from a United States Cohort.
    Jabs DA; Ahuja A; Van Natta ML; Lyon AT; Yeh S; Danis R;
    Ophthalmology; 2015 Jul; 122(7):1452-63. PubMed ID: 25892019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual field loss in patients with cytomegalovirus retinitis.
    Thorne JE; Van Natta ML; Jabs DA; Duncan JL; Srivastava SK;
    Ophthalmology; 2011 May; 118(5):895-901. PubMed ID: 21146225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela.
    Arevalo JF; Garcia RA; Mendoza AJ
    Eur J Ophthalmol; 2005; 15(5):610-8. PubMed ID: 16167292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
    Whitcup SM; Fortin E; Lindblad AS; Griffiths P; Metcalf JA; Robinson MR; Manischewitz J; Baird B; Perry C; Kidd IM; Vrabec T; Davey RT; Falloon J; Walker RE; Kovacs JA; Lane HC; Nussenblatt RB; Smith J; Masur H; Polis MA
    JAMA; 1999 Nov; 282(17):1633-7. PubMed ID: 10553789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune recovery uveitis in AIDS patients with cytomegalovirus retinitis treated with highly active antiretroviral therapy in Venezuela.
    Arevalo JF; Mendoza AJ; Ferretti Y
    Retina; 2003 Aug; 23(4):495-502. PubMed ID: 12972761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus Retinitis in Patients With Acquired Immunodeficiency Syndrome After Initiating Antiretroviral Therapy.
    Jabs DA; Van Natta ML; Holland GN; Danis R;
    Am J Ophthalmol; 2017 Feb; 174():23-32. PubMed ID: 27984023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
    Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
    Retina; 2000; 20(2):151-5. PubMed ID: 10783947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis.
    Kempen JH; Min YI; Freeman WR; Holland GN; Friedberg DN; Dieterich DT; Jabs DA;
    Ophthalmology; 2006 Apr; 113(4):684-94. PubMed ID: 16581429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis.
    Macdonald JC; Karavellas MP; Torriani FJ; Morse LS; Smith IL; Reed JB; Freeman WR
    Ophthalmology; 2000 May; 107(5):877-81; discussion 881-3. PubMed ID: 10811078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of combination antiretroviral therapy on cytomegalovirus retinitis.
    Banker AS; Patel A
    Indian J Ophthalmol; 2002 Mar; 50(1):29-33. PubMed ID: 12090084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment.
    Jabs DA; Van Natta ML; Holbrook JT; Kempen JH; Meinert CL; Davis MD;
    Ophthalmology; 2007 Apr; 114(4):780-6. PubMed ID: 17258320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of treatment regimens for cytomegalovirus retinitis in patients with AIDS in the era of highly active antiretroviral therapy.
    Jabs DA; Ahuja A; Van Natta M; Dunn JP; Yeh S;
    Ophthalmology; 2013 Jun; 120(6):1262-70. PubMed ID: 23419804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune recovery vitritis and uveitis in AIDS: clinical predictors, sequelae, and treatment outcomes.
    Karavellas MP; Azen SP; MacDonald JC; Shufelt CL; Lowder CY; Plummer DJ; Glasgow B; Torriani FJ; Freeman WR
    Retina; 2001; 21(1):1-9. PubMed ID: 11217922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus retinitis and the acquired immunodeficiency syndrome--bench to bedside: LXVII Edward Jackson Memorial Lecture.
    Jabs DA
    Am J Ophthalmol; 2011 Feb; 151(2):198-216.e1. PubMed ID: 21168815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Sugar EA; Jabs DA; Ahuja A; Thorne JE; Danis RP; Meinert CL;
    Am J Ophthalmol; 2012 Jun; 153(6):1016-24.e5. PubMed ID: 22310076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Whitcup SM
    JAMA; 2000 Feb; 283(5):653-7. PubMed ID: 10665706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.